- Crystalys mines $130M series B to push gout drug through phase 3Crystalys Therapeutics has raised $130 million in series B financing to advance the development of its gout drug dotinurad and prepare for a potential commercial launch.<br>Fierce Biotech · 3d ago↗ source
- Is there an exodus underway at Epic?In this edition of STAT Health Tech: executive departures at Epic Systems, new CEO takes over at Nabla, and more health tech news.STAT · 3d ago↗ source
- STAT+: Broad Institute, partners unveil new initiative to develop gene therapies for rare diseasesThe Broad Institute, Boston Children’s Hospital, and Maine’s Jackson Laboratory announced a collaboration to develop rare disease gene therapies.STAT · 3d ago